Pretraživanje
Prikaz rezultata 1-4 od 4
Expression of Fas/FasL in patients with oral lichen planus
(Balkan Union of Oncology (B.U.ON.), 2009)
Purpose: To investigate the malignant potential of oral lichen planus (OLP) on the basis of expression of the Fas/FasL markers in healthy individuals (H), OLP patients and patients with squamous cell carcinoma (SCC). ...
Ki-67 expression in oral lichen planus
(Balkan Union of Oncology (B.U.ON.), 2012)
Purpose: The monoclonal antibody Ki-67 detects a nuclear antigen that is present only in proliferating cells. This is of particular interest for the analysis of the proliferation rates of malignant tumors. The aim of this ...
Bcl-2 expression and its possible influence on malignant transformation of oral lichen planus
(Balkan Union of Oncology (B.U.ON.), 2010)
Purpose: The aim of this study was to investigate the malignant potential of oral lichen planus (OLP) on the basis of the expression of the Bcl-2 marker in healthy individuals (H), patients with OLP and patients with ...
Expression and role of p53 in oral lichen planus patients
(Balkan Union of Oncology (B.U.ON.), 2017)
Purpose: Oral lichen planus (OLP) is an autoimmune skin and mucosal disorder. The range of malignant transformation in OLP varies between 0.1-3%. p53 is a tumor suppressor protein. Defective p53 could allow abnormal cells ...